Updated:
Esperante Ventures
Esperante Ventures, a Dutch venture firm, currently shows a 'Coming Soon' website with no disclosed operators, portfolio, or AUM.
Esperante Ventures
Esperante Ventures is a corporate venture firm founded in 2004 in London, U.K. It invests in life sciences, pharmaceutical, and diagnostic sectors. The firm has made 25 investments, including an unattributed VC investment in AMLo Biosciences on November 26, 2024.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
Netherlands
City
Hoofddorp
Corporate office
Hoofddorp, Netherlands
Frequently asked questions
What is Esperante Ventures' investment strategy?
Esperante Ventures has not disclosed any investment strategy. As of mid-2026, the firm's website is under reconstruction, and no information is publicly available on its targeted sectors, stages, or investment vehicles.
Who runs Esperante Ventures?
The principals of Esperante Ventures are not publicly known. The firm's website, the only identified official source, is under reconstruction and does not list a team or leadership.
Is Esperante Ventures currently active?
Esperante Ventures' operational status cannot be determined from public sources. The firm's residence at a Dutch address is confirmed, but with no recent investment activity, regulatory filings, or public announcements available, there is no verifiable indication of current capital deployment.
How large is Esperante Ventures?
Esperante Ventures has not publicly disclosed its assets under management or any deployment figures. Without a firm website, regulatory disclosure, or media mention, no Altss estimate can be made.
Does Esperante Ventures accept external capital?
There is no public information on whether Esperante Ventures raises external capital or operates with a proprietary mandate. The firm's Type is listed as 'Asset Manager' in some databases, which may or may not indicate a multi-client structure.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: